← Open Payments lookup

JESSICA NGUYEN-BINDER: Open Payments

NPI 1801162466 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$360 in 20 payments from 9 companies in 2025. Trend: 2023 $195 · 2024 $257 · 2025 $360

Food & beverage: $360
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.4$70
Lilly USA, LLC3$69
Amgen Inc.4$61
Bayer Healthcare Pharmaceuticals Inc.2$36
GlaxoSmithKline, LLC.2$34
Salix Pharmaceuticals, a division of Bausch Health US, LLC2$32
Phathom Pharmaceuticals, Inc.1$22
Merck Sharp & Dohme LLC1$18
AstraZeneca Pharmaceuticals LP1$18

Products named: REXULTI, JARDIANCE, Kerendia, XIFAXAN, OTEZLA, VOQUEZNA, AREXVY, GARDASIL 9.

Industry payments across MD — which companies pay providers there.